Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02554019
What this trial is testing

Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Biotest 36
Not applicableStudy completedNCT04527172
What this trial is testing

Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus

Who this might be right for
Peripheral NeuropathySystem; Lupus Erythematosus
Assiut University 55
Not applicableUnknownNCT05253638
What this trial is testing

Evaluation Of Serum MIF Level in SLE Patients

Who this might be right for
Systemic Lupus Erythematosus
Assiut University 60
Not applicableStudy completedNCT01475149
What this trial is testing

Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)

Who this might be right for
Antiphospholipid SyndromeThrombophilia Due to Antiphospholipid AntibodySystemic Lupus Erythematosus
Hospital for Special Surgery, New York 33
Early research (Phase 1)Study completedNCT00001676
What this trial is testing

Cyclophosphamide and Fludarabine to Treat Lupus Nephritis

Who this might be right for
GlomerulonephritisLupus NephritisSystemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 15
Early research (Phase 1)Study completedNCT02391259
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Amgen 57
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Early research (Phase 1)Active Not RecruitingNCT06335979
What this trial is testing

An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE).

Who this might be right for
Systemic Lupus Erythematosus, SLE
Novartis Pharmaceuticals 54
Not applicableStudy completedNCT01180361
What this trial is testing

Atherosclerosis in Rheumatoid Arthritis and Lupus: Restoring Cholesterol Balance

Who this might be right for
Rheumatoid Arthritis
NYU Langone Health 176
Testing effectiveness (Phase 2)Study completedNCT00997100
What this trial is testing

Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Active Biotech AB 13
Not applicableStudy completedNCT00006134
What this trial is testing

Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture

Who this might be right for
Systemic Lupus Erythematosus
National Center for Research Resources (NCRR) 300
Testing effectiveness (Phase 2)Ended earlyNCT05306873
What this trial is testing

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID) 12
Large-scale testing (Phase 3)Active Not RecruitingNCT03747159
What this trial is testing

Synergetic B-cell Immunomodulation in SLE - 2nd Study.

Who this might be right for
Lupus Erythematosus, Systemic
Leiden University Medical Center 70
Not applicableNot Yet RecruitingNCT06610422
What this trial is testing

Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients

Who this might be right for
Lupus Nephritis
Assiut University 159
Large-scale testing (Phase 3)Study completedNCT03427151
What this trial is testing

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
ImmuPharma 62
Not applicableStudy completedNCT01230112
What this trial is testing

The Role of ITGAM in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Northwell Health 40
Early research (Phase 1)Study completedNCT00731302
What this trial is testing

Aspirin Resistance in Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Vanderbilt University 70
Not applicableLooking for participantsNCT06314282
What this trial is testing

INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use

Who this might be right for
Systemic Lupus Erythematosus (SLE)
AstraZeneca 200
Testing effectiveness (Phase 2)Ended earlyNCT03407482
What this trial is testing

An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Genentech, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Next Page